Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 27,151 followers.

RT @FrontOncology: New research: Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in…

25 Jan 2024

Reply Repost Favourite

New research: Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practice: Non-metastatic castration-resistant prostate cancer (nmCRPC) represents a challenging disease state in… https://t.co/

24 Jan 2024

Reply Repost Favourite

RT @gedefo_sefh: Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practic…

23 Jan 2024

Reply Repost Favourite

RT @gedefo_sefh: Improving the identification of high-risk non-metastatic castration-resistant prostate cancer patients in clinical practic…

23 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.